Spots Global Cancer Trial Database for Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

Official Title: Effect of Liraglutide on Different Parameters (Clinical , Metabolic and Hormonal) in Obese Women With Polycystic Ovary Syndrome

Study ID: NCT05965908

Conditions

Polycystic Ovary

Interventions

liraglutide

Metformin

Study Description

Brief Summary: The aim of this study is to compare the hormonal, metabolic and clinical effects of metformin and liraglutide in infertile women with PCOs.

Detailed Description: It is a Prospective randomized controlled trial .The study will include 80 randomly selected infertile women aged between 18 and 45 years, from Gynecology and obstetrics department Beni-Suef University Hospital whom diagnosed with polycystic ovarian syndrome (PCOS), The study will include two groups; each group consists of 40 patients:- * Group1 (n=40) will be treated by liraglutide monotherapy. * Group 2 (n=40) will be treated by metformin monotherapy. * Group 3 (n=40) will be a control group. To assess the metabolic effect of each treatment, the following parameters will be assessed before and after the treatment * To assess the hormonal effect of each treatment, the following tests will be assessed before and after treatment * Total Testosterone (TT) * Dehydroepiandrosterone (DHEA) To assess the clinical effect of the drugs, the following will be assessed before and after treatment: The number of medium size follicles and large size follicles and the endometrium thickness were assessed on the tenth or eleventh day of menstruation. The chemical and clinical pregnancy rates were evaluated